Class information for:
Level 1: AIDS RELATED LYMPHOMA//NON AIDS DEFINING CANCER//NON AIDS DEFINING CANCERS

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
4027 1787 37.9 78%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
39 32196 MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 AIDS RELATED LYMPHOMA Author keyword 19 49% 2% 28
2 NON AIDS DEFINING CANCER Author keyword 18 89% 0% 8
3 NON AIDS DEFINING CANCERS Author keyword 15 77% 1% 10
4 HIV ASSOCIATED LYMPHOMA Author keyword 13 71% 1% 10
5 NON AIDS DEFINING MALIGNANCIES Author keyword 11 69% 1% 9
6 HIV RELATED LYMPHOMA Author keyword 9 83% 0% 5
7 AIDS LYMPHOMA Author keyword 7 57% 0% 8
8 AIDS DEFINING MALIGNANCIES Author keyword 6 100% 0% 4
9 HIV ASSOCIATED HODGKIN LYMPHOMA Author keyword 6 100% 0% 4
10 HIV LYMPHOMA Author keyword 4 67% 0% 4

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 AIDS RELATED LYMPHOMA 19 49% 2% 28 Search AIDS+RELATED+LYMPHOMA Search AIDS+RELATED+LYMPHOMA
2 NON AIDS DEFINING CANCER 18 89% 0% 8 Search NON+AIDS+DEFINING+CANCER Search NON+AIDS+DEFINING+CANCER
3 NON AIDS DEFINING CANCERS 15 77% 1% 10 Search NON+AIDS+DEFINING+CANCERS Search NON+AIDS+DEFINING+CANCERS
4 HIV ASSOCIATED LYMPHOMA 13 71% 1% 10 Search HIV+ASSOCIATED+LYMPHOMA Search HIV+ASSOCIATED+LYMPHOMA
5 NON AIDS DEFINING MALIGNANCIES 11 69% 1% 9 Search NON+AIDS+DEFINING+MALIGNANCIES Search NON+AIDS+DEFINING+MALIGNANCIES
6 HIV RELATED LYMPHOMA 9 83% 0% 5 Search HIV+RELATED+LYMPHOMA Search HIV+RELATED+LYMPHOMA
7 AIDS LYMPHOMA 7 57% 0% 8 Search AIDS+LYMPHOMA Search AIDS+LYMPHOMA
8 AIDS DEFINING MALIGNANCIES 6 100% 0% 4 Search AIDS+DEFINING+MALIGNANCIES Search AIDS+DEFINING+MALIGNANCIES
9 HIV ASSOCIATED HODGKIN LYMPHOMA 6 100% 0% 4 Search HIV+ASSOCIATED+HODGKIN+LYMPHOMA Search HIV+ASSOCIATED+HODGKIN+LYMPHOMA
10 HIV LYMPHOMA 4 67% 0% 4 Search HIV+LYMPHOMA Search HIV+LYMPHOMA

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 INFUSIONAL CYCLOPHOSPHAMIDE 120 91% 3% 50
2 AIDS RELATED LYMPHOMA 89 65% 5% 85
3 VIRUS RELATED LYMPHOMA 36 83% 1% 20
4 HIV ASSOCIATED LYMPHOMA 27 74% 1% 20
5 AIDS DEFINING CANCERS 25 58% 2% 29
6 AIDS DEFINING MALIGNANCIES 23 59% 1% 26
7 DEFINING CANCERS 18 89% 0% 8
8 ORAL COMBINATION CHEMOTHERAPY 14 100% 0% 7
9 PREDNISONE CHEMOTHERAPY 13 71% 1% 10
10 HIGHLY ACTIVE REGIMEN 11 78% 0% 7

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges 2014 12 128 40%
Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: A systematic review 2015 1 40 75%
Diagnosis and management of lymphomas and other cancers in HIV-infected patients 2014 8 152 49%
ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED LYMPHOMA 1992 294 89 46%
How I treat HIV-associated lymphoma 2012 28 83 41%
The Challenge of AIDS-Related Malignancies in Sub-Saharan Africa 2010 29 88 48%
Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection 2012 8 21 67%
Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk 2014 3 79 46%
Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings 2012 10 36 56%
Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years 2011 31 44 43%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 REGISTRO TUMORI LIGURE 4 75% 0.2% 3
2 STEM CELL ECT PROC UNIT 4 75% 0.2% 3
3 CANC REGISTRY CANTON VAUD 3 100% 0.2% 3
4 MACERATA PROV CANC MORTAL REGISTRY 3 100% 0.2% 3
5 UGANDA CANC 3 35% 0.3% 6
6 CELLULAR THER Y HIGH DOSE CHEMOTHER Y UNIT 2 67% 0.1% 2
7 INFECT DIS B 2 67% 0.1% 2
8 INFECT IMMUNOEPIDEMIOL BRANCH 2 11% 1.0% 18
9 REGISTRO TUMORI VENETO 2 23% 0.4% 7
10 COORDINAT DATA 2 29% 0.3% 5

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000290031 PLASMABLASTIC LYMPHOMA//PLASMABLASTIC//HUMAN IMMUNODEFICIENCY VIRUS NEGATIVE
2 0.0000123847 CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS//HIV IN WOMEN//CERVICAL DYSPLASIA
3 0.0000107727 KAPOSIS SARCOMA//HUMAN HERPESVIRUS 8//KAPOSI SARCOMA
4 0.0000102069 LYMPHOBLASTIC LYMPHOMA//BURKITTS LYMPHOMA//BURKITT LYMPHOMA
5 0.0000100178 VIETNAM EVIDENCE HLTH POLICY PROJECT//CELL PHONE INTERVENTION//NON AIDS RELATED MORTALITY
6 0.0000080275 DIFFUSE INFILTRATIVE LYMPHOCYTOSIS SYNDROME//BENIGN LYMPHOEPITHELIAL CYSTS//DILS
7 0.0000076905 ANAL CANCER//ANAL INTRAEPITHELIAL NEOPLASIA//ANAL CARCINOMA
8 0.0000075667 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA//PRIMARY CNS LYMPHOMA//PCNSL
9 0.0000070473 NELFINAVIR//SAQUINAVIR NO//ANTIRETROVIRALL THERAPY
10 0.0000064164 AIDS CHOLANGIOPATHY//ANAL DISEASES//ANAL ULCER